{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:09:00Z","timestamp":1779286140353,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,20]]},"DOI":"10.7759\/cureus.109279","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T13:27:57Z","timestamp":1779283677000},"source":"Crossref","is-referenced-by-count":0,"title":["Severe Hyperferritinemia in Metabolic Dysfunction-Associated Steatotic Liver Disease With Normal Transferrin Saturation and Polyclonal Hypergammaglobulinemia Mimicking Iron Overload"],"prefix":"10.7759","author":[{"given":"Niyas Khalid","family":"Ottu Para","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgey","family":"Koshy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Rab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig J","year":"1980","unstructured":"Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980, 55:434-8.","journal-title":"Mayo Clin Proc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"Marchesini G","year":"2001","unstructured":"Marchesini G, Brizi M, Bianchi G, et al.. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001, 50:1844-50. 10.2337\/diabetes.50.8.1844","journal-title":"Diabetes"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning JD","year":"2004","unstructured":"Browning JD, Szczepaniak LS, Dobbins R, et al.. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004, 40:1387-95. 10.1002\/hep.20466","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.10.3505","article-title":"Regulation of ferritin genes and protein","volume":"99","author":"Torti FM","year":"2002","unstructured":"Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood. 2002, 99:3505-16. 10.1182\/blood.v99.10.3505","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI20945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth E","year":"2004","unstructured":"Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004, 113:1271-6. 10.1172\/JCI20945","journal-title":"J Clin Invest"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.06.028","article-title":"Two to tango: regulation of Mammalian iron metabolism","volume":"142","author":"Hentze MW","year":"2010","unstructured":"Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of Mammalian iron metabolism. Cell. 2010, 142:24-38. 10.1016\/j.cell.2010.06.028","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-258467","article-title":"Hepcidin and iron regulation, 10 years later","volume":"117","author":"Ganz T","year":"2011","unstructured":"Ganz T. Hepcidin and iron regulation, 10 years later. Blood. 2011, 117:4425-33. 10.1182\/blood-2011-01-258467","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61782-6","article-title":"Haemochromatosis","volume":"370","author":"Adams PC","year":"2007","unstructured":"Adams PC, Barton JC. Haemochromatosis. Lancet. 2007, 370:1855-60. 10.1016\/S0140-6736(07)61782-6","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg H","year":"2010","unstructured":"Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010, 52:1836-46. 10.1002\/hep.24001","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.03.052","article-title":"Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1\u03b2 in mice","volume":"139","author":"Miura K","year":"2010","unstructured":"Miura K, Kodama Y, Inokuchi S, et al.. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1\u03b2 in mice. Gastroenterology. 2010, 139:323-34.e7. 10.1053\/j.gastro.2010.03.052","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2014.04.002","article-title":"Use of magnetic resonance imaging to monitor iron overload","volume":"28","author":"Wood JC","year":"2014","unstructured":"Wood JC. Use of magnetic resonance imaging to monitor iron overload. Hematol Oncol Clin North Am. 2014, 28:747-64. 10.1016\/j.hoc.2014.04.002","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/1532-429X-16-40","article-title":"Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan","volume":"16","author":"Garbowski MW","year":"2014","unstructured":"Garbowski MW, Carpenter JP, Smith G, et al.. Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan. J Cardiovasc Magn Reson. 2014, 16:40. 10.1186\/1532-429X-16-40","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong MJ","year":"2016","unstructured":"Armstrong MJ, Gaunt P, Aithal GP, et al.. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. Lancet. 2016, 387:679-90. 10.1016\/S0140-6736(15)00803-X","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal AJ","year":"2021","unstructured":"Sanyal AJ, Van Natta ML, Clark J, et al.. Prospective study of outcomes in adults with nonalcoholic fatty liver disease. N Engl J Med. 2021, 385:1559-69. 10.1056\/NEJMoa2029349","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo S","year":"2008","unstructured":"Romeo S, Kozlitina J, Xing C, et al.. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008, 40:1461-5. 10.1038\/ng.257","journal-title":"Nat Genet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/491554-severe-hyperferritinemia-in-metabolic-dysfunction-associated-steatotic-liver-disease-with-normal-transferrin-saturation-and-polyclonal-hypergammaglobulinemia-mimicking-iron-overload","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T13:27:58Z","timestamp":1779283678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/491554-severe-hyperferritinemia-in-metabolic-dysfunction-associated-steatotic-liver-disease-with-normal-transferrin-saturation-and-polyclonal-hypergammaglobulinemia-mimicking-iron-overload"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.109279","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,20]]}}}